The ENDpoiNTs Project : Novel Testing Strategies for Endocrine Disruptors Linked to Developmental Neurotoxicity
The ENDpoiNTs Project : Novel Testing Strategies for Endocrine Disruptors Linked to Developmental Neurotoxicity
Lade...
Datum
2020
Autor:innen
Lupu, Diana
Andersson, Patrik
Bornehag, Carl-Gustaf
Demeneix, Barbara
Fritsche, Ellen
Gennings, Chris
Lichtensteiger, Walter
Leonards, Pim E. G.
Ponsonby, Anne-Louise
Herausgeber:innen
ISSN der Zeitschrift
eISSN
item.preview.dc.identifier.isbn
Bibliografische Daten
Verlag
Schriftenreihe
URI (zitierfähiger Link)
DOI (zitierfähiger Link)
Internationale Patentnummer
Link zur Lizenz
EU-Projektnummer
825759
Projekt
ENDpoiNTs
Open Access-Veröffentlichung
Sammlungen
Titel in einer weiteren Sprache
Publikationstyp
Zeitschriftenartikel
Publikationsstatus
Published
Erschienen in
International Journal of Molecular Sciences (IJMS) ; 21 (2020), 11. - 3978. - Molecular Diversity Preservation International (MDPI). - eISSN 1422-0067
Zusammenfassung
Ubiquitous exposure to endocrine-disrupting chemicals (EDCs) has caused serious concerns about the ability of these chemicals to affect neurodevelopment, among others. Since endocrine disruption (ED)-induced developmental neurotoxicity (DNT) is hardly covered by the chemical testing tools that are currently in regulatory use, the Horizon 2020 research and innovation action ENDpoiNTs has been launched to fill the scientific and methodological gaps related to the assessment of this type of chemical toxicity. The ENDpoiNTs project will generate new knowledge about ED-induced DNT and aims to develop and improve in vitro, in vivo, and in silico models pertaining to ED-linked DNT outcomes for chemical testing. This will be achieved by establishing correlative and causal links between known and novel neurodevelopmental endpoints and endocrine pathways through integration of molecular, cellular, and organismal data from in vitro and in vivo models. Based on this knowledge, the project aims to provide adverse outcome pathways (AOPs) for ED-induced DNT and to develop and integrate new testing tools with high relevance for human health into European and international regulatory frameworks.
Zusammenfassung in einer weiteren Sprache
Fachgebiet (DDC)
570 Biowissenschaften, Biologie
Schlagwörter
endocrine-disrupting chemicals; developmental neurotoxicity; chemical testing; adverse outcome pathways
Konferenz
Rezension
undefined / . - undefined, undefined. - (undefined; undefined)
Zitieren
ISO 690
LUPU, Diana, Patrik ANDERSSON, Carl-Gustaf BORNEHAG, Barbara DEMENEIX, Ellen FRITSCHE, Chris GENNINGS, Walter LICHTENSTEIGER, Marcel LEIST, Pim E. G. LEONARDS, Anne-Louise PONSONBY, 2020. The ENDpoiNTs Project : Novel Testing Strategies for Endocrine Disruptors Linked to Developmental Neurotoxicity. In: International Journal of Molecular Sciences (IJMS). Molecular Diversity Preservation International (MDPI). 21(11), 3978. eISSN 1422-0067. Available under: doi: 10.3390/ijms21113978BibTex
@article{Lupu2020-06-01ENDpo-50593, year={2020}, doi={10.3390/ijms21113978}, title={The ENDpoiNTs Project : Novel Testing Strategies for Endocrine Disruptors Linked to Developmental Neurotoxicity}, number={11}, volume={21}, journal={International Journal of Molecular Sciences (IJMS)}, author={Lupu, Diana and Andersson, Patrik and Bornehag, Carl-Gustaf and Demeneix, Barbara and Fritsche, Ellen and Gennings, Chris and Lichtensteiger, Walter and Leist, Marcel and Leonards, Pim E. G. and Ponsonby, Anne-Louise}, note={Article Number: 3978} }
RDF
<rdf:RDF xmlns:dcterms="http://purl.org/dc/terms/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:bibo="http://purl.org/ontology/bibo/" xmlns:dspace="http://digital-repositories.org/ontologies/dspace/0.1.0#" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:void="http://rdfs.org/ns/void#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" > <rdf:Description rdf:about="https://kops.uni-konstanz.de/server/rdf/resource/123456789/50593"> <dc:creator>Fritsche, Ellen</dc:creator> <dc:contributor>Andersson, Patrik</dc:contributor> <dc:creator>Leonards, Pim E. G.</dc:creator> <dc:creator>Andersson, Patrik</dc:creator> <dc:creator>Lichtensteiger, Walter</dc:creator> <foaf:homepage rdf:resource="http://localhost:8080/"/> <dcterms:issued>2020-06-01</dcterms:issued> <dc:contributor>Fritsche, Ellen</dc:contributor> <dspace:hasBitstream rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/50593/1/Lupu_2-cab0xux9jd7v5.pdf"/> <dcterms:title>The ENDpoiNTs Project : Novel Testing Strategies for Endocrine Disruptors Linked to Developmental Neurotoxicity</dcterms:title> <dcterms:rights rdf:resource="http://creativecommons.org/licenses/by/4.0/"/> <dc:contributor>Lichtensteiger, Walter</dc:contributor> <bibo:uri rdf:resource="https://kops.uni-konstanz.de/handle/123456789/50593"/> <dc:contributor>Lupu, Diana</dc:contributor> <dc:contributor>Leonards, Pim E. G.</dc:contributor> <dcterms:abstract xml:lang="eng">Ubiquitous exposure to endocrine-disrupting chemicals (EDCs) has caused serious concerns about the ability of these chemicals to affect neurodevelopment, among others. Since endocrine disruption (ED)-induced developmental neurotoxicity (DNT) is hardly covered by the chemical testing tools that are currently in regulatory use, the Horizon 2020 research and innovation action ENDpoiNTs has been launched to fill the scientific and methodological gaps related to the assessment of this type of chemical toxicity. The ENDpoiNTs project will generate new knowledge about ED-induced DNT and aims to develop and improve in vitro, in vivo, and in silico models pertaining to ED-linked DNT outcomes for chemical testing. This will be achieved by establishing correlative and causal links between known and novel neurodevelopmental endpoints and endocrine pathways through integration of molecular, cellular, and organismal data from in vitro and in vivo models. Based on this knowledge, the project aims to provide adverse outcome pathways (AOPs) for ED-induced DNT and to develop and integrate new testing tools with high relevance for human health into European and international regulatory frameworks.</dcterms:abstract> <dc:creator>Demeneix, Barbara</dc:creator> <dc:creator>Lupu, Diana</dc:creator> <dc:creator>Gennings, Chris</dc:creator> <dc:contributor>Demeneix, Barbara</dc:contributor> <dc:creator>Ponsonby, Anne-Louise</dc:creator> <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/> <dc:creator>Leist, Marcel</dc:creator> <dc:contributor>Bornehag, Carl-Gustaf</dc:contributor> <dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-08-27T11:29:09Z</dcterms:available> <dc:language>eng</dc:language> <dc:rights>Attribution 4.0 International</dc:rights> <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/> <dc:contributor>Ponsonby, Anne-Louise</dc:contributor> <dc:creator>Bornehag, Carl-Gustaf</dc:creator> <dc:contributor>Leist, Marcel</dc:contributor> <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-08-27T11:29:09Z</dc:date> <void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/> <dc:contributor>Gennings, Chris</dc:contributor> <dcterms:hasPart rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/50593/1/Lupu_2-cab0xux9jd7v5.pdf"/> </rdf:Description> </rdf:RDF>
Interner Vermerk
xmlui.Submission.submit.DescribeStep.inputForms.label.kops_note_fromSubmitter
Prüfungsdatum der Dissertation
Finanzierungsart
Kommentar zur Publikation
Allianzlizenz
Corresponding Authors der Uni Konstanz vorhanden
Internationale Co-Autor:innen
Universitätsbibliographie
Ja
Begutachtet
Ja